Medline’s Founding Family Has $6 Billion-Plus Stake In Its Upcoming Blockbuster IPO
PositiveFinancial Markets

- The Mills family, having previously sold a majority stake in Medline to private equity in 2021, is poised to benefit significantly from the company's upcoming IPO, which is projected to be valued at $50 billion. Forbes estimates the family's remaining stake is worth over $6 billion, contributing to their overall wealth of approximately $20 billion.
- This IPO marks a pivotal moment for Medline, as it seeks to solidify its position in the public market and leverage its substantial valuation to fuel future growth and expansion in the medical supplies sector.
- The anticipated IPO reflects broader trends in the market, where companies in the healthcare sector are increasingly turning to public offerings to capitalize on investor interest and secure funding for innovation and expansion, highlighting the ongoing evolution of the medical supplies industry.
— via World Pulse Now AI Editorial System







